spacer
The Healthcare Sales & Marketing Network celebrates 23 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  OMRIX Biopharmaceuticals 

 HSMN NewsFeed - 24 Nov 2021
BD Names Francesca DeMartino as Senior Vice President of Investor Relations
Devices Diagnostics Personnel
 HSMN NewsFeed - 1 Sep 2010
Syneron Appoints New Chief Financial Officer
Devices Personnel
 HSMN NewsFeed - 27 Dec 2008
Johnson & Johnson Completes Tender Offer for Omrix Biopharmaceuticals, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 24 Nov 2008
Johnson & Johnson Announces Definitive Agreement to Acquire Omrix
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 14 Oct 2008
Omrix Biopharmaceuticals Receives Approval from European Medicines Agency for Evicel Liquid Fibrin Sealant (Human)
Biopharmaceuticals Wound Care Regulatory
 HSMN NewsFeed - 25 Jul 2008
Omrix Biopharmaceuticals Receives Positive Opinion from Committee for Medicinal Products for Human Use (CHMP) for Evicel(TM) Liquid Fibrin Sealant (Human)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 1 Feb 2008
Omrix Biopharmaceuticals Announces Key Changes to Senior Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Sep 2007
Study Shows Plasma-Derived Human Thrombin Equivalent to Bovine Thrombin in Achieving Hemostasis in Surgery
Biopharmaceuticals
 HSMN NewsFeed - 28 Aug 2007
OMRIX Biopharmaceuticals Receives Food and Drug Administration (FDA) Approval for Thrombin Stand Alone, EVITHROM* Thrombin, Topical (Human), with General Hemostasis in Surgery Indication
Biopharmaceuticals Wound Care Surgery FDA
 HSMN NewsFeed - 30 Jul 2007
OMRIX Biopharmaceuticals Submits Market Authorization Application (MAA) to European Medicines Agency (EMEA) for Approval to Market Evicel(TM) with General Hemostasis Indication
Biopharmaceuticals Surgery Regulatory
 HSMN NewsFeed - 23 Jul 2007
NeuroDerm Raises $2.5 Million in Series A Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 6 Jul 2007
OMRIX Biopharmaceuticals Receives Food and Drug Administration (FDA) Approval to Use Cryoprecipitate from Talecris Biotherapeutics, Inc. in Its Manufacturing Process
Biopharmaceuticals FDA
 HSMN NewsFeed - 15 May 2007
OMRIX Biopharmaceuticals Receives Food and Drug Administration (FDA) Approval for Liquid Fibrin Sealant, Evicel(TM), For Use in Vascular Surgery
Devices FDA
 HSMN NewsFeed - 7 May 2007
OMRIX Biopharmaceuticals Submits Regulatory Filing for Hepatitis B Immunoglobulin (HBIG) in Sweden
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 5 Apr 2007
OMRIX Biopharmaceuticals Announces Departure of Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Mar 2007
OMRIX Biopharmaceuticals Submits Supplemental Biologics License Application (sBLA) to Market Evicel With General Hemostasis in Surgery Indication
Biopharmaceuticals Surgery
 HSMN NewsFeed - 19 Jan 2007
OMRIX Biopharmaceuticals Announces Appointments to Board of Directors and Executive Management Team Promotions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Dec 2006
OMRIX Biopharmaceuticals Files Investigational New Drug (IND) Application For Anti-Adhesion Product Candidate and Announces Recent Milestone Achievements
Biopharmaceuticals Surgery FDA
 HSMN NewsFeed - 6 Nov 2006
OMRIX Biopharmaceuticals Submits Biologics License Application (BLA) for Human Thrombin Stand-Alone Product
Biopharmaceuticals
 HSMN NewsFeed - 16 Oct 2006
OMRIX Biopharmaceuticals Announces Positive Phase 3 Clinical Trial Results for Human Thrombin
Biopharmaceuticals Surgery
 HSMN NewsFeed - 29 Sep 2006
OMRIX Biopharmaceuticals Announces New Strategic Product Development Programs
Biopharmaceuticals Surgery Orthopaedic
 HSMN NewsFeed - 28 Aug 2006
OMRIX Biopharmaceuticals Announces Appointment of Nanci Prado to General Counsel
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Aug 2006
OMRIX Biopharmaceuticals Announces U.S. Phase III Clinical Trial for Intravenous Immunoglobulin (IVIG) in Subjects with Primary Immune Deficiency Diseases
Biopharmaceuticals
 HSMN NewsFeed - 10 Jul 2006
OMRIX Biopharmaceuticals Receives FDA Approval for Second Generation Fibrin Sealant, Evicel(TM), For Use in Liver Surgery
Devices Surgery FDA
 HSMN NewsFeed - 26 Jun 2006
Enrollment in Phase III Clinical Trial for OMRIX's Thrombin Stand-Alone Product Has Been Completed
Biopharmaceuticals
Return to NewsFeed  

 Additional items found! 2

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 2 additional stories matching:
OMRIX Biopharmaceuticals
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.